InvestorsHub Logo

kei

03/18/15 7:22 AM

#86795 RE: Mark #86350

$ATNM news out --> https://finance.yahoo.com/news/actinium-announces-data-ongoing-phase-110000334.html

Actinium Announces New Data From Ongoing Phase 1/2 Trial of Actimab-A Demonstrating Safety and Robust Clinical Efficacy in High Risk Elderly Acute Myeloid Leukemia Patients
Strong Anti-Leukemic Effect Demonstrated in Cohort 3; No Dose Limiting Toxicities Observed